STK-012pembrolizumabmSTK-012cancerNCT05098132Non-small cell lung cancerNSCLC
…mab and chemotherapy. These findings highlight the potential of STK-012 to overcome key limitations of the next wave immunotherapies by…
1articles mentioning drugs
5drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: mSTK-012 ×
mSTK-012
This drug is selected. Its supporting articles are shown below.